Organs on a chip

submitted by: nsf

Organs on a chip systems could transform the medical drug pipeline as we know it. Biomedical engineer Ali Khademhosseini explains how he and his team at MIT are engineering tissues outside of the human body and connecting different "organs" to solve some pressing challenges.

Engineering a Smart Bandaid

submitted by: nsf

What does it take to engineer a smart bandaid? Biomedical engineer Ali Khademhosseini walks us through the future of bandaids, and how he and his team at MIT are testing them.

An in-mouth wafer to treat oral cancer– Biotech’s future

submitted by: nsf

To treat oral cancer, NSF-funded small business Privo Technologies has created a platform that delivers treatments directly to the affected area. Privo develops new classes of targeted treatments, such as chemotherapy drugs, designed to be delivered through the mouth’s mucous membranes. Privo founder Manijeh Goldberg talked about her company’s research at the 2014 BIO International Convention.

Faster, more sensitive imaging of live cells – Biotech’s future

submitted by: nsf

Developing new drugs means researchers must observe how cells react to those drugs over extended periods of time. NSF-funded small business Phi Optics has developed an optical microscope that lets scientists do just that -- study living cells in their natural environments. Catalin Chiritescu talked about how the technology works at the 2014 BIO International Convention.

Cancer-scanning device detects residual cancer cells post-surgery – Biotech’s future

submitted by: nsf

Despite a surgeon’s best efforts, residual cancer cells often remain after a tumor is removed. Now, a technology from NSF-funded small business NovaScan detects cancer cells in living tissue in real-time. The cancer-scanning device has already been used to find breast cancer cells. NovaScan’s William Gregory talked about how the wand works at the 2014 BIO International Convention.

Leveraging the immune system to fight cancer – Biotech’s future

submitted by: nsf

Inventors are using small-scale biology and engineering to find ways to use the body’s natural defenses to effectively treat cancer. NSF-funded small business GigaGen uses microfluidics, bioinformatics and genome sequencing to look for antibodies that may be good candidates for new therapies. GigaGen’s David Johnson explained how at the 2014 BIO International Convention.